Abstract

Review Article

Human Monkeypox Virus Severity

Vandna Kumari, Gaurav Sharma, Mohil and Shamsher S Kanwar*

Published: 16 June, 2023 | Volume 7 - Issue 1 | Pages: 014-020

Monkeypox is a sylvatic zoonotic sickness that initially affected tropical rainforest areas in the west and vital Africa earlier than spreading to other places. Its miles carried with the aid of the Monkeypox virus member of orthopoxvirus circle of relatives. The clinical features of the infection resembles to smallpox. The primary animal to human transmission is the cause of most people of human Monkeypox ailments. Severe rodent species and non-human primates function hosts for the virus. Transmission can manifest with infected people, animals or objects into contact with bodily fluids, sores on the skin or inner mucosal surfaces just like the mouth or throat, or breathing droplets. The incubation length for Monkeypox usually lasts 6 to 13 days, even though it could last as long as 21 days. The ailment is often self-proscribing, with signs and symptoms generally clearing up on their own inside 14 to 21 days. Signs can range from moderate to extreme, and lesions may be itchy or painful. Due to the discontinuation of recurring smallpox vaccination which supplied some pass- safety in past, populations have become more liable to Monkey pox. The outbreak of Monkeypox virus due to the fact that may additionally, 2022 has created a worldwide risk of the virus. In the present review, Monkeypox epidemiology, severity, therapeutics, vaccination and its transmission to non-endemic countries has been considered. Special care and guidelines may help in the containing in the spread of the infections to the non endemic countries.

Read Full Article HTML DOI: 10.29328/journal.apb.1001021 Cite this Article Read Full Article PDF

Keywords:

Monkeypox; Epidemiology; Zoonotic disease; Prevention; Transmission

References

  1. Antinori A, Mazzotta V, Vita S, Carletti F, Tacconi D, Lapini LE, D'Abramo A, Cicalini S, Lapa D, Pittalis S, Puro V, Rivano Capparuccia M, Giombini E, Gruber CEM, Garbuglia AR, Marani A, Vairo F, Girardi E, Vaia F, Nicastri E; INMI Monkeypox Group. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Surveill. 2022 Jun;27(22):2200421. doi: 10.2807/1560-7917.ES.2022.27.22.2200421. PMID: 35656836; PMCID: PMC9164671.
  2. Reynolds MG, Yorita KL, Kuehnert MJ, Davidson WB, Huhn GD, Holman RC, Damon IK. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis. 2006 Sep 15;194(6):773-80. doi: 10.1086/505880. Epub 2006 Aug 8. PMID: 16941343.
  3. Vaughan A, Aarons E, Astbury J, Brooks T, Chand M, Flegg P, Hardman A, Harper N, Jarvis R, Mawdsley S, McGivern M, Morgan D, Morris G, Nixon G, O'Connor C, Palmer R, Phin N, Price DA, Russell K, Said B, Schmid ML, Vivancos R, Walsh A, Welfare W, Wilburn J, Dunning J. Human-to-Human Transmission of Monkeypox Virus, United Kingdom, October 2018. Emerg Infect Dis. 2020 Apr;26(4):782-785. doi: 10.3201/eid2604.191164. Epub 2020 Apr 17. PMID: 32023204; PMCID: PMC7101111.
  4. Mahase E. Monkeypox: What do we know about the outbreaks in Europe and North America? BMJ. 2022 May 20;377:o1274. doi: 10.1136/bmj.o1274. PMID: 35595274.
  5. Moss B. Poxviridae: The viruses and their replication. In “Fields Virology” (DM. Knipe, Howley PM. Eds. Lippincott, Williams & Wilkins, Philadelphia. 2: 2849–2883.
  6. Erez N, Achdout H, Milrot E, Schwartz Y, Wiener-Well Y, Paran N, Politi B, Tamir H, Israely T, Weiss S, Beth-Din A, Shifman O, Israeli O, Yitzhaki S, Shapira SC, Melamed S, Schwartz E. Diagnosis of Imported Monkeypox, Israel, 2018. Emerg Infect Dis. 2019 May;25(5):980-983. doi: 10.3201/eid2505.190076. Epub 2019 May 17. PMID: 30848724; PMCID: PMC6478227.
  7. Costello V, Sowash M, Gaur A, Cardis M, Pasieka H, Wortmann G, Ramdeen S. Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerg Infect Dis. 2022 May;28(5):1002-1005. doi: 10.3201/eid2805.220292. Epub 2022 Mar 9. PMID: 35263559; PMCID: PMC9045429.
  8. Marennikova SS, Seluhina EM, Mal'ceva NN, Ladnyj ID. Poxviruses isolated from clinically ill and asymptomatically infected monkeys and a chimpanzee. Bull World Health Organ. 1972;46(5):613-20. PMID: 4340220; PMCID: PMC2480788.
  9. Magnus P, Andersen EK, Petersen KB, Birch-Andersen A. A Pox-like Disease in Cynomolgus Monkeys. Acta Pathologica Microbiologica Scandinavica. 1959; 46(2):156–76. https://doi.org/10.1111/j.1699-0463.1959.tb00328.x
  10. Doty JB, Malekani JM, Kalemba LN, Stanley WT, Monroe BP, Nakazawa YU, Mauldin MR, Bakambana TL, Liyandja Dja Liyandja T, Braden ZH, Wallace RM, Malekani DV, McCollum AM, Gallardo-Romero N, Kondas A, Peterson AT, Osorio JE, Rocke TE, Karem KL, Emerson GL, Carroll DS. Assessing Monkeypox Virus Prevalence in Small Mammals at the Human-Animal Interface in the Democratic Republic of the Congo. Viruses. 2017 Oct 3;9(10):283. doi: 10.3390/v9100283. PMID: 28972544; PMCID: PMC5691634.
  11. Hutin YJ, Williams RJ, Malfait P, Pebody R, Loparev VN, Ropp SL, Rodriguez M, Knight JC, Tshioko FK, Khan AS, Szczeniowski MV, Esposito JJ. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 2001 May-Jun;7(3):434-8. doi: 10.3201/eid0703.010311. PMID: 11384521; PMCID: PMC2631782.
  12. Systematic review human Monkey pox outbreaks. PLOS Neglected Tropical Diseases https://doi.org/10.1371/journal.pntd.0007791 October 16, 2019 16 / 20
  13. Khodakevich L, Jezek Z, Messinger D. Monkeypox virus: ecology and public health significance. Bull World Health Organ. 1988;66(6):747-52. PMID: 2853010; PMCID: PMC2491157.
  14. Jezek Z, Grab B, Szczeniowski M, Paluku KM, Mutombo M. Clinico-epidemiological features of monkeypox patients with an animal or human source of infection. Bull World Health Organ. 1988;66(4):459-64. PMID: 2844428; PMCID: PMC2491168.
  15. Reynolds MG, Carroll DS, Olson VA, Hughes C, Galley J, Likos A, Montgomery JM, Suu-Ire R, Kwasi MO, Jeffrey Root J, Braden Z, Abel J, Clemmons C, Regnery R, Karem K, Damon IK. A silent enzootic of an orthopoxvirus in Ghana, West Africa: evidence for multi-species involvement in the absence of widespread human disease. Am J Trop Med Hyg. 2010 Apr;82(4):746-54. doi: 10.4269/ajtmh.2010.09-0716. PMID: 20348530; PMCID: PMC2844556.
  16. Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: clinical features of 282 patients. J Infect Dis. 1987 Aug;156(2):293-8. doi: 10.1093/infdis/156.2.293. PMID: 3036967.
  17. Mbala PK, Huggins JW, Riu-Rovira T, Ahuka SM, Mulembakani P, Rimoin AW, Martin JW, Muyembe JT. Maternal and Fetal Outcomes Among Pregnant Women With Human Monkeypox Infection in the Democratic Republic of Congo. J Infect Dis. 2017 Oct 17;216(7):824-828. doi: 10.1093/infdis/jix260. PMID: 29029147.
  18. Withers MR, Kingebeni PM, Muyembe JJT, Martin J, Riu-Rovira T, Huggins J. Outcome of fourpregnancies in congolese women with Monkey pox infection. American Journal of Tropical Medicineand Hygiene. 2011; (1):397. PMID: 71043487.
  19. Kisalu NK, Mokili JL. Toward Understanding the Outcomes of Monkeypox Infection in Human Pregnancy. J Infect Dis. 2017 Oct 17;216(7):795-797. doi: 10.1093/infdis/jix342. PMID: 29029238; PMCID: PMC6279131.
  20. Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988 Sep;17(3):643-50. doi: 10.1093/ije/17.3.643. PMID: 2850277.
  21. Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull. 1998;54(3):693-702. doi: 10.1093/oxfordjournals.bmb.a011720. PMID: 10326294.
  22. Meyer H, Perrichot M, Stemmler M, Emmerich P, Schmitz H, Varaine F, Shungu R, Tshioko F, Formenty P. Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol. 2002 Aug;40(8):2919-21. doi: 10.1128/JCM.40.8.2919-2921.2002. PMID: 12149352; PMCID: PMC120683.
  23. Mutombo M, Arita I, Jezek Z. Human monkeypox transmitted by a chimpanzee in a tropical rain-forest area of Zaire. Lancet. 1983 Apr 2;1(8327):735-7. doi: 10.1016/s0140-6736(83)92027-5. PMID: 6132084; PMCID: PMC9534202.
  24. Reynolds MG, Yorita KL, Kuehnert MJ, Davidson WB, Huhn GD, Holman RC, Damon IK. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis. 2006 Sep 15;194(6):773-80. doi: 10.1086/505880. Epub 2006 Aug 8. PMID: 16941343.
  25. Jezek Z, Grab B, Paluku KM, Szczeniowski MV. Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire. Trop Geogr Med. 1988 Apr;40(2):73-83. PMID: 2841783.
  26. Jezek Z, Grab B, Szczeniowski MV, Paluku KM, Mutombo M. Human Monkey pox: secondary attackrates. Bulletin of the World Health Organization. 1988; 66(4):465–70. PMID: 2844429.
  27. Parker S, Nuara A, Buller RM, Schultz DA. Human Monkey pox: an emerging zoonotic disease. FutureMicrobiology. 2007; 2(1):17–34. https://doi.org/10.2217/17460913.2.1.17 PMID: 17661673.
  28. Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, Davidson W, Galloway R, Khristova ML, Reynolds MG, Zhao H, Carroll DS, Curns A, Formenty P, Esposito JJ, Regnery RL, Damon IK. A tale of two clades: monkeypox viruses. J Gen Virol. 2005 Oct;86(Pt 10):2661-2672. doi: 10.1099/vir.0.81215-0. PMID: 16186219.
  29. Panning M, Asper M, Kramme S, Schmitz H, Drosten C. Rapid detection and differentiation of human pathogenic orthopox viruses by a fluorescence resonance energy transfer real-time PCR assay. Clin Chem. 2004 Apr;50(4):702-8. doi: 10.1373/clinchem.2003.026781. Epub 2004 Feb 12. PMID: 14962998.
  30. Neubauer H, Reischl U, Ropp S, Esposito JJ, Wolf H, Meyer H. Specific detection of monkeypox virus by polymerase chain reaction. J Virol Methods. 1998 Oct;74(2):201-7. doi: 10.1016/s0166-0934(98)00099-8. PMID: 9779620.
  31. Li Y, Olson VA, Laue T, Laker MT, Damon IK. Detection of monkeypox virus with real-time PCR assays. J Clin Virol. 2006 Jul;36(3):194-203. doi: 10.1016/j.jcv.2006.03.012. Epub 2006 May 30. PMID: 16731033; PMCID: PMC9628957.
  32. Jezek Z, Szczeniowski M, Paluku KM, Mutombo M, Grab B. Human monkeypox: confusion with chickenpox. Acta Trop. 1988 Dec;45(4):297-307. PMID: 2907258.
  33. Hoff NA, Morier DS, Kisalu NK, Johnston SC, Doshi RH, Hensley LE, Okitolonda-Wemakoy E, Muyembe-Tamfum JJ, Lloyd-Smith JO, Rimoin AW. Varicella Coinfection in Patients with Active Monkeypox in the Democratic Republic of the Congo. Ecohealth. 2017 Sep;14(3):564-574. doi: 10.1007/s10393-017-1266-5. Epub 2017 Sep 11. PMID: 28894977.
  34. MacNeil A, Reynolds MG, Carroll DS, Karem K, Braden Z, Lash R, Moundeli A, Mombouli JV, Jumaan AO, Schmid DS, Damon IK. Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo. Am J Trop Med Hyg. 2009 Apr;80(4):503-7. PMID: 19346366.
  35. Reynolds MG, McCollum AM, Nguete B, Shongo Lushima R, Petersen BW. Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research. Viruses. 2017 Dec 12;9(12):380. doi: 10.3390/v9120380. PMID: 29231870; PMCID: PMC5744154.
  36. World health organisation (WHO). Multi-country Monkey pox outbreak: situation update, 17 June 2022. WHO https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON393.
  37. European Centre for Disease Prevention and Control (ECDC). Monkey pox multi-country outbreak. Situation update, 22 June 2022. Stockholm: ECDC. https://www.ecdc.europa.eu/en/Monkey pox-outbreak
  38. World health network (WHN), The WHN declares Monkey pox a pandemic. 28 June 2022. https://www.worldhealthnetwork.global/.
  39. Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019 Oct 16;13(10):e0007791. doi: 10.1371/journal.pntd.0007791. PMID: 31618206; PMCID: PMC6816577.
  40. Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, Kazmierczak JJ, Stratman EJ, Li Y, Fairley JA, Swain GR, Olson VA, Sargent EK, Kehl SC, Frace MA, Kline R, Foldy SL, Davis JP, Damon IK. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004 Jan 22;350(4):342-50. doi: 10.1056/NEJMoa032299. PMID: 14736926.
  41. Damon IK. Status of human monkeypox: clinical disease, epidemiology and research. Vaccine. 2011 Dec 30;29 Suppl 4:D54-9. doi: 10.1016/j.vaccine.2011.04.014. Epub 2011 Dec 18. PMID: 22185831.
  42. Miura F, van Ewijk CE, Backer JA, Xiridou M, Franz E, Op de Coul E, Brandwagt D, van Cleef B, van Rijckevorsel G, Swaan C, van den Hof S, Wallinga J. Estimated incubation period for monkeypox cases confirmed in the Netherlands, May 2022. Euro Surveill. 2022 Jun;27(24):2200448. doi: 10.2807/1560-7917.ES.2022.27.24.2200448. PMID: 35713026; PMCID: PMC9205160.
  43. Pal M, Singh R, Gutama KP, Savalia CV, Thakur R. Human Monkey pox: An emerging and re-emerging infectious viral disease. Acta Scientific Microbiology. 2022 Apr;5(4).
  44. Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, Damon IK, Reynolds MG, Kuehnert MJ. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005 Dec 15;41(12):1742-51. doi: 10.1086/498115. Epub 2005 Nov 11. PMID: 16288398.
  45. Islam MR, Hossain MJ, Roy A, Hasan AHMN, Rahman MA, Shahriar M, Bhuiyan MA. Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks. Health Sci Rep. 2022 Aug 23;5(5):e798. doi: 10.1002/hsr2.798. Erratum in: Health Sci Rep. 2022 Nov 01;5(6):e897. PMID: 36032515; PMCID: PMC9399446.
  46. Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis. 2005 Dec 15;41(12):1765-71. doi: 10.1086/498155. Epub 2005 Nov 11. PMID: 16288402.
  47. Reynolds MG, McCollum AM, Nguete B, Shongo Lushima R, Petersen BW. Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research. Viruses. 2017 Dec 12;9(12):380. doi: 10.3390/v9120380. PMID: 29231870; PMCID: PMC5744154.
  48. Guagliardo SAJ, Monroe B, Moundjoa C, Athanase A, Okpu G, Burgado J, Townsend MB, Satheshkumar PS, Epperson S, Doty JB, Reynolds MG, Dibongue E, Etoundi GA, Mathieu E, McCollum AM. Asymptomatic Orthopoxvirus Circulation in Humans in the Wake of a Monkeypox Outbreak among Chimpanzees in Cameroon. Am J Trop Med Hyg. 2020 Jan;102(1):206-212. doi: 10.4269/ajtmh.19-0467. PMID: 31769389; PMCID: PMC6947779.
  49. Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, Osborne JC, Rampling T, Beadsworth MB, Duncan CJ, Dunning J, Fletcher TE, Hunter ER, Jacobs M, Khoo SH, Newsholme W, Porter D, Porter RJ, Ratcliffe L, Schmid ML, Semple MG, Tunbridge AJ, Wingfield T, Price NM; NHS England High Consequence Infectious Diseases (Airborne) Network. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022 Aug;22(8):1153-1162. doi: 10.1016/S1473-3099(22)00228-6. Epub 2022 May 24. Erratum in: Lancet Infect Dis. 2022 Jul;22(7):e177. Erratum in: Lancet Infect Dis. 2022 Jul;22(7):e177. PMID: 35623380; PMCID: PMC9300470..
  50. Russo AT, Grosenbach DW, Brasel TL, Baker RO, Cawthon AG, Reynolds E, Bailey T, Kuehl PJ, Sugita V, Agans K, Hruby DE. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques. J Infect Dis. 2018 Sep 22;218(9):1490-1499. doi: 10.1093/infdis/jiy326. PMID: 29982575; PMCID: PMC6151088.
  51. Hoy SM. Tecovirimat: First Global Approval. Drugs. 2018 Sep;78(13):1377-1382. doi: 10.1007/s40265-018-0967-6. PMID: 30120738.
  52. Vivancos R, Anderson C, Blomquist P, Balasegaram S, Bell A, Bishop L, Brown CS, Chow Y, Edeghere O, Florence I, Logan S, Manley P, Crowe W, McAuley A, Shankar AG, Mora-Peris B, Paranthaman K, Prochazka M, Ryan C, Simons D, Vipond R, Byers C, Watkins NA; UKHSA Monkeypox Incident Management team; Welfare W, Whittaker E, Dewsnap C, Wilson A, Young Y, Chand M, Riley S, Hopkins S; Monkeypox Incident Management Team. Community transmission of monkeypox in the United Kingdom, April to May 2022. Euro Surveill. 2022 Jun;27(22):2200422. doi: 10.2807/1560-7917.ES.2022.27.22.2200422. Erratum in: Euro Surveill. 2022 Jun;27(23): PMID: 35656834; PMCID: PMC9164677.
  53. Mauldin MR, McCollum AM, Nakazawa YJ, Mandra A, Whitehouse ER, Davidson W, Zhao H, Gao J, Li Y, Doty J, Yinka-Ogunleye A, Akinpelu A, Aruna O, Naidoo D, Lewandowski K, Afrough B, Graham V, Aarons E, Hewson R, Vipond R, Dunning J, Chand M, Brown C, Cohen-Gihon I, Erez N, Shifman O, Israeli O, Sharon M, Schwartz E, Beth-Din A, Zvi A, Mak TM, Ng YK, Cui L, Lin RTP, Olson VA, Brooks T, Paran N, Ihekweazu C, Reynolds MG. Exportation of Monkeypox Virus From the African Continent. J Infect Dis. 2022 Apr 19;225(8):1367-1376. doi: 10.1093/infdis/jiaa559. PMID: 32880628; PMCID: PMC9016419.

Figures:

Similar Articles

  • Human Monkeypox Virus Severity
    Vandna Kumari, Gaurav Sharma, Mohil and Shamsher S Kanwar* Vandna Kumari, Gaurav Sharma, Mohil, Shamsher S Kanwar*. Human Monkeypox Virus Severity. . 2023 doi: 10.29328/journal.apb.1001021; 7: 014-020

Recently Viewed

Read More

Most Viewed

Read More

Help ?